Association between frequent CpG island methylation and HER2 amplification in human breast cancers

被引：0
|
作者：
Terada, Kotoe
Okochi-Takada, Eriko
Akashi-Tanaka, Sadako
Miyamoto, Kazuaki
Taniyama, Kiyomi
Tsuda, Hitoshi
Asada, Kiyoshi
Kaminishi, Michio
Ushijima, Toshikazu
机构：
[1] Natl Canc Ctr, Res Inst, Tokyo 1040045, Japan
[2] Natl Canc Ctr, Tokyo, Japan
[3] Kure Med Ctr, Natl Hosp Org, Kure, Japan
[4] Univ Tokyo, Sch Med, Tokyo 113, Japan
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-165
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Association between frequent CpG island methylation and HER2 amplification in human breast cancers
    Terada, Kotoe
    Okochi-Takada, Eriko
    Akashi-Tanaka, Sadako
    Miyamoto, Kazuaki
    Taniyama, Kiyomi
    Tsuda, Hitoshi
    Asada, Kiyoshi
    Kaminishi, Michio
    Ushijima, Toshikazu
    CARCINOGENESIS, 2009, 30 (03) : 466 - 471
  • [2] Association between CpG Island Methylation of the WWOX Gene and Its Expression in Breast Cancers
    Wang, X.
    Chao, L.
    Jin, G.
    Ma, G.
    Zang, Y.
    Sun, J.
    TUMOR BIOLOGY, 2009, 30 (01) : 8 - 14
  • [3] Activating HER2 mutations in HER2 gene amplification negative breast cancers.
    Bose, R.
    Kavuri, S. M.
    Searleman, A. C.
    Shen, W.
    Shen, D.
    Koboldt, D. C.
    Monsey, J.
    Li, S.
    Ding, L.
    Mardis, E. R.
    Ellis, M. J.
    CANCER RESEARCH, 2012, 72
  • [4] Adjuvant chemotherapy of breast cancers with overexpression or HER2 amplification
    Petit, Thierry
    ONCOLOGIE, 2008, 10 : S64 - S67
  • [5] Analysis of HER2 amplification and IGF-IR expression in CETCs and its possible association with resistance to trastuzumab in HER2 positive breast cancers
    Zimon, D.
    Pizon, M.
    Pachmann, U.
    Pachmann, K.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S76 - S76
  • [6] Genomic characterisation of invasive breast cancers with heterogeneous HER2 gene amplification
    Ng, C. K. Y.
    Gauthier, A.
    Mackay, A.
    Lambros, M. B. K.
    Rodrigues, D. N.
    Arnoud, L.
    Lacroix-Triki, M.
    Penault-Llorca, F.
    Baranzelli, M. C.
    Sastre-Garau, X.
    Lord, C. J.
    Zvelebil, M.
    Mitsopoulos, C.
    Ashworth, A.
    Natrajan, R.
    Weigelt, B.
    Delattre, O.
    Cottu, P.
    Reis-Filho, J. S.
    Vincent-Salomon, A.
    CANCER RESEARCH, 2012, 72
  • [7] Pathological complete response rates in HER2 amplified breast cancers based on levels of HER2 amplification.
    Patel, Ina
    Hashimie, Yasmeen
    Hall, James
    Bhat, Ashwini
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] The diverse molecular landscape of breast cancers with heterogeneous HER2 gene amplification
    Van Bockstal, M. R.
    Agahozo, M. C.
    van Marion, R.
    Atmodimedjo, P. N.
    Sleddens, H. F.
    Dinjens, W.
    Visser, L. L.
    Lips, E.
    Wesseling, J.
    van Deurzen, C. H.
    VIRCHOWS ARCHIV, 2020, 477 : S55 - S55
  • [9] Frequent Heterogeneity of HER2 Amplification in Colorectal Carcinoma
    Chevarie-Davis, M.
    Baden, K.
    Fournier, P.
    Magat, M. C.
    Thorpe, E.
    Lopategui, J.
    LABORATORY INVESTIGATION, 2014, 94 : 168A - 168A
  • [10] Frequent Heterogeneity of HER2 Amplification in Colorectal Carcinoma
    Chevarie-Davis, M.
    Baden, K.
    Fournier, P.
    Magat, M. C.
    Thorpe, E.
    Lopategui, J.
    MODERN PATHOLOGY, 2014, 27 : 168A - 168A
12345